Biblio
Export 136 results:
[ Author
Filters: First Letter Of Last Name is R [Clear All Filters]
“Statins and Brain Health: Alzheimer's Disease and Cerebrovascular Disease Biomarkers in Older Adults.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1345-1352, 2018.
, “Non-Verbal Episodic Memory Deficits in Primary Progressive Aphasias are Highly Predictive of Underlying Amyloid Pathology.”, J Alzheimers Dis, vol. 51, no. 2, pp. 367-76, 2016.
, “Polygenic Scores of Alzheimer's Disease Risk Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1615-1625, 2022.
, “Substance Use-Related Cognitive Decline in Families with Autosomal Dominant Alzheimer's Disease: A Cohort Study.”, J Alzheimers Dis, vol. 85, no. 4, pp. 423-1439, 2021.
, “Effect of Normal Aging and of Mild Cognitive Impairment on Event-Related Potentials to a Stroop Color-Word Task.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1487-501, 2016.
, “Alzheimer's Disease, Visual Search, and Instrumental Activities of Daily Living: A Review and a New Perspective on Attention and Eye Movements.”, J Alzheimers Dis, vol. 66, no. 3, pp. 901-925, 2018.
, “Curcumin Inhibits Tau Aggregation and Disintegrates Preformed Tau Filaments in vitro.”, J Alzheimers Dis, vol. 60, no. 3, pp. 999-1014, 2017.
, “Caregiving and Caregiver Burden in Dementia Home Care: Results from the Prospective Dementia Registry (PRODEM) of the Austrian Alzheimer Society.”, J Alzheimers Dis, vol. 63, no. 1, pp. 103-114, 2018.
, “Cleveland Clinic Cognitive Battery (C3B): Normative, Reliability, and Validation Studies of a Self-Administered Computerized Tool for Screening Cognitive Dysfunction in Primary Care.”, J Alzheimers Dis, vol. 92, no. 3, pp. 1051-1066, 2023.
, “Thrombin Signaling Contributes to High Glucose-Induced Injury of Human Brain Microvascular Endothelial Cells.”, J Alzheimers Dis, vol. 79, no. 1, pp. 211-224, 2021.
, “The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1145-55, 2016.
, “Soluble TREM2 and Inflammatory Proteins in Alzheimer's Disease Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1615-1626, 2020.
, “Amygdala α-Synuclein Pathology in the Population-Based Vantaa 85+ Study.”, J Alzheimers Dis, vol. 58, no. 3, pp. 669-674, 2017.
, “Triceps and Subscapular Skinfold in Men Aged 40-65 and Dementia Prevalence 36 Years Later.”, J Alzheimers Dis, vol. 57, no. 3, pp. 873-883, 2017.
, “Psychosocial Risk and Protective Factors and Incident Mild Cognitive Impairment and Dementia in Community Dwelling Elderly: Findings from the Singapore Longitudinal Ageing Study.”, J Alzheimers Dis, vol. 57, no. 2, pp. 603-611, 2017.
, “Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 62, no. 1, pp. 467-476, 2018.
, “Ten-year effects of the advanced cognitive training for independent and vital elderly cognitive training trial on cognition and everyday functioning in older adults.”, J Am Geriatr Soc, vol. 62, no. 1, pp. 16-24, 2014.
, “Frontotemporal Dementia and Chorea Associated with a Compound Heterozygous TREM2 Mutation.”, J Alzheimers Dis, vol. 63, no. 1, pp. 195-201, 2018.
, “A Critical Assessment of Research on Neurotransmitters in Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 4, pp. 969-974, 2017.
, “Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 3, pp. 843-866, 2018.
, “Mitochondria-Division Inhibitor 1 Protects Against Amyloid-β induced Mitochondrial Fragmentation and Synaptic Damage in Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 1, pp. 147-162, 2017.
, “Synergistic Protective Effects of Mitochondrial Division Inhibitor 1 and Mitochondria-Targeted Small Peptide SS31 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1549-1565, 2018.
, “Prevalence of Potentially Inappropriate Medication Use in Older Inpatients with and without Cognitive Impairment: A Systematic Review.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1639-1652, 2018.
, “What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study.”, J Alzheimers Dis, vol. 57, no. 3, pp. 797-812, 2017.
, “Monophosphoryl Lipid-A: A Promising Tool for Alzheimer's Disease Toll.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1189-202, 2016.
,